Analysis of osteosarcoma subtypes by clinical genomic testing to identify clinically actionable alterations.
Sign Up to like & getrecommendations! Published in 2017 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2017.35.15_suppl.11019
Abstract: 11019Background: Genomic testing is being utilized with increasing frequency to identify matched therapies for patients (pts) with advanced disease; however, the utility of such testing has not bee... read more here.
Keywords: subtypes clinical; testing identify; clinical genomic; analysis osteosarcoma ... See more keywords